Richard Dubinsky

7.7k total citations · 1 hit paper
55 papers, 4.4k citations indexed

About

Richard Dubinsky is a scholar working on Neurology, Cellular and Molecular Neuroscience and General Health Professions. According to data from OpenAlex, Richard Dubinsky has authored 55 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Neurology, 14 papers in Cellular and Molecular Neuroscience and 7 papers in General Health Professions. Recurrent topics in Richard Dubinsky's work include Neurological disorders and treatments (15 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Genetic Neurodegenerative Diseases (9 papers). Richard Dubinsky is often cited by papers focused on Neurological disorders and treatments (15 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Genetic Neurodegenerative Diseases (9 papers). Richard Dubinsky collaborates with scholars based in United States, Canada and Guatemala. Richard Dubinsky's co-authors include Jeffrey Kaye, Steven T. DeKosky, Jeffrey L. Cummings, Rachelle S. Doody, Richard C. Mohs, Lisa P. Gwyther, J E Stevens, L. J. Thal, Peter J. Whitehouse and C. Beck and has published in prestigious journals such as Brain, Neurology and Journal of Neurochemistry.

In The Last Decade

Richard Dubinsky

51 papers receiving 4.1k citations

Hit Papers

Practice parameter: Management of dementia (an evidence-b... 2001 2026 2009 2017 2001 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Dubinsky United States 29 1.9k 1.3k 946 811 424 55 4.4k
Rodolfo Savica United States 38 3.1k 1.6× 1.2k 0.9× 1.3k 1.3× 794 1.0× 609 1.4× 169 5.7k
Seyed‐Mohammad Fereshtehnejad Iran 33 2.5k 1.3× 952 0.7× 725 0.8× 411 0.5× 370 0.9× 200 4.7k
Robin Conwit United States 40 1.3k 0.7× 1.2k 0.9× 1.1k 1.1× 633 0.8× 410 1.0× 116 6.7k
Péter Novák United States 38 1.5k 0.8× 403 0.3× 780 0.8× 617 0.8× 457 1.1× 136 4.3k
Douglas J. Lanska United States 35 1.2k 0.6× 918 0.7× 553 0.6× 454 0.6× 680 1.6× 186 4.6k
Marc Verny France 33 2.3k 1.2× 1.1k 0.8× 1.4k 1.5× 694 0.9× 777 1.8× 133 4.9k
Félix Bermejo‐Pareja Spain 45 2.8k 1.5× 1.4k 1.0× 1.0k 1.1× 1.4k 1.7× 417 1.0× 155 6.1k
Allison W. Willis United States 30 2.3k 1.2× 643 0.5× 482 0.5× 552 0.7× 273 0.6× 137 4.0k
Andrea Pilotto Italy 36 1.6k 0.9× 687 0.5× 964 1.0× 355 0.4× 416 1.0× 164 4.9k
Cynthia A. Munro United States 34 512 0.3× 1.7k 1.3× 618 0.7× 410 0.5× 315 0.7× 89 4.2k

Countries citing papers authored by Richard Dubinsky

Since Specialization
Citations

This map shows the geographic impact of Richard Dubinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Dubinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Dubinsky more than expected).

Fields of papers citing papers by Richard Dubinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Dubinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Dubinsky. The network helps show where Richard Dubinsky may publish in the future.

Co-authorship network of co-authors of Richard Dubinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Dubinsky. A scholar is included among the top collaborators of Richard Dubinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Dubinsky. Richard Dubinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Litvan, Irene, David G. Standaert, Joseph Jankovic, et al.. (2020). Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. Parkinsonism & Related Disorders. 78. 56–60. 7 indexed citations
3.
Zesiewicz, Theresa A., George Wilmot, Sheng‐Han Kuo, et al.. (2018). Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia [RETIRED]. Neurology. 90(10). 464–471. 88 indexed citations
4.
Armstrong, Melissa J., Gary Gronseth, Richard Dubinsky, et al.. (2017). Naturalistic study of guideline implementation tool use via evaluation of website access and physician survey. BMC Medical Informatics and Decision Making. 17(1). 9–9. 4 indexed citations
5.
Jabari, Duaa, Mazen M. Dimachkie, Jeffrey Statland, et al.. (2015). Stiff Person Syndrome: A case series (P7.053). Neurology. 84(14_supplement).
6.
Bhattacharya, Rajib, et al.. (2014). Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample. Journal of Multidisciplinary Healthcare. 7. 119–119. 9 indexed citations
7.
Bhattacharya, Rajib, et al.. (2012). Is there an increased risk of hip fracture in Parkinson's disease? A nationwide inpatient sample. Movement Disorders. 27(11). 1440–1442. 37 indexed citations
8.
Esteves, A. Raquel, Mariana Rodova, Isaac G. Onyango, et al.. (2010). Mitochondrial respiration and respiration‐associated proteins in cell lines created through Parkinson’s subject mitochondrial transfer. Journal of Neurochemistry. 113(3). 674–682. 60 indexed citations
9.
Jackson, Carlayne E., Gary Gronseth, Jeffrey Rosenfeld, et al.. (2009). Randomized double‐blind study of botulinum toxin type B for sialorrhea in als patients. Muscle & Nerve. 39(2). 137–143. 107 indexed citations
10.
Dubinsky, Richard & Carolyn Steele Gray. (2005). CYTE‐I‐HD: Phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease. Movement Disorders. 21(4). 530–533. 68 indexed citations
11.
Hoffman, Lesa, Joan M. McDowd, Paul Atchley, & Richard Dubinsky. (2005). The role of visual attention in predicting driving impairment in older adults.. Psychology and Aging. 20(4). 610–622. 85 indexed citations
12.
Dubinsky, Richard. (2005). No going home for hospitalized Huntington's disease patients. Movement Disorders. 20(10). 1316–1322. 27 indexed citations
13.
Dubinsky, Richard, et al.. (1997). EMG Analysis in Disorders of Extrapyramidal Systems (About Basal ganglia and cerebellum). Journal of the Korean Geriatrics Society. 1(1). 71–83. 1 indexed citations
14.
Hallett, Mark, Richard Dubinsky, Thomas A. Zeffiro, & Samuel M. Bierner. (1994). Comparison of Glucose Metabolism and Cerebral Blood Flow During Cortical Motor Activation. Journal of Neuroimaging. 4(1). 1–5. 12 indexed citations
15.
Koller, William C., Karen Busenbark, Carolyn Steele Gray, Ruth S. Hassanein, & Richard Dubinsky. (1992). Classification of Essential Tremor. Clinical Neuropharmacology. 15(2). 81–87. 26 indexed citations
16.
Fulham, Michael, Richard Dubinsky, Ronald J. Polinsky, et al.. (1991). Computed tomography, magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in multiple system atrophy and pure autonomic failure. Clinical Autonomic Research. 1(1). 27–36. 25 indexed citations
17.
Hallett, Mark, et al.. (1991). A double‐blind trial of isoniazid for essential tremor and other action tremors. Movement Disorders. 6(3). 253–256. 13 indexed citations
18.
Cohen, Leonardo G., Jacob Meer, Ina M. Tarkka, et al.. (1991). CONGENITAL MIRROR MOVEMENTS. Brain. 114(1). 381–403. 111 indexed citations
19.
Dubinsky, Richard, et al.. (1989). Hemiballismus: Study of a case using positron emission tomography with 18f1uoro‐2‐deoxyg1ucose. Movement Disorders. 4(4). 310–319. 9 indexed citations
20.
Dubinsky, Richard, et al.. (1989). Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′‐dideoxycytidine (ddc). Muscle & Nerve. 12(10). 856–860. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026